KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Opko Health (OPK) Current Deferred Revenue (2023 - 2024)

Opko Health filings provide 4 years of Current Deferred Revenue readings, the most recent being $6000.0 for Q4 2024.

On a quarterly basis, Current Deferred Revenue fell 14.29% to $6000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $6000.0, a 14.29% decrease, with the full-year FY2024 number at $6000.0, down 14.29% from a year prior.
Current Deferred Revenue hit $6000.0 in Q4 2024 for Opko Health, down from $7000.0 in the prior quarter.
In the past five years, Current Deferred Revenue ranged from a high of $7000.0 in Q4 2023 to a low of $6000.0 in Q4 2024.